The guidelines recommend a 4-month drug regimen for adults and children with drug-susceptible TB, and a 6-month regimen for those with drug-resistant TB.
Executive Director of Government Affairs Kent Bacus issued a statement following the latest court development that has once again put the Corporate Transparency Act reporting requirements temporarily ...